The Ledger
Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.
why aren't all 9 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable
Dr. Moore: GLP-1s actively heal metabolic pathways beyond suppressing appetite
“They're not just working by decreasing your, you know, stomach motility. They're not just making you feel fuller longer. They're not just shutting down your appetite in your brain. They're not, that's not where it ends. They actually are healing metabolic path…”
Dan Go: Ozempic Users Without Resistance Training Risk Osteoporosis and Severe Muscle Loss
“Like, I've seen people go on Ozempic and not eat high protein, not do resistance training, and then we're starting to see that people are coming up with osteoporosis. Starting to see people lose a shit ton of lean mass.”
Sanchez: Ozempic costs under $5 to make but sells for $1,000 monthly
“Well, Yale says that Ozempic costs less than five dollars a month to manufacture, And yet we're getting charged a thousand dollars a month for this drug. While the exact same product can be bought in Canada for a 155 dollars a month and 59 dollars a month in G…”
Israetel: Tirzepatide outperforms Ozempic, with more potent fifth-gen GLP drugs in trials
“Technically it's a third generation GLP drug, but fourth gen is Trisapatide. It's already on the market, Manjaro. Fewer side effects, bigger primary effect. There are fifth gen drugs currently in FDA approval process, which make Ozempic look like a starter pac…”
Sanchez: Eli Lilly and Novo Nordisk could become trillion-dollar stocks
“And I realized that they might actually create the first trillion-dollar drug stocks. So the two companies, Eli Lilly and Novo Nordisk, could be trillion-dollar drug stocks.”
Dan Go: Hunger Remains Elevated for Three to Six Months After Stopping Ozempic
“The struggle bus period is like the three to even six months where your hunger is going to be elevated as a result of getting off of Ozempic.”
Israetel: GLP-1 drugs curb obesity primarily by lowering genetic food drive
“New medications like Ozempic, Trisapatide, et cetera, Manjaro, all those things. While, why they were some of the only things to really take a big chunk out of obesity is because they take your, whatever genetic food drive and palatability drive you have, how …”